Jl. Bashford et al., DEVELOPMENT OF AN ANTIIDIOTYPIC ANTIBODY-REACTIVE WITH AN ANTIBODY DEFINING THE EPITOPE R P A P IN THE MUC-1 EPITHELIAL MUCIN CORE, International journal of cancer, 54(5), 1993, pp. 778-783
C595 is a murine IgG3 monoclonal antibody (MAb) raised against human u
rinary mucin. C595 antibody binds to the protein core of the MUC-1 muc
in (the polymorphic epithelial mucin, PEM) which is elevated in tissue
and secretions from human breast carcinomas. The antibody defines the
tetrameric epitope, R P A P. In the present study, a syngeneic anti-i
diotypic MAb, 911, was raised in BALB/c mice against the C595 antibody
. This IgG2a anti-idiotypic antibody blocked the binding of C595 to it
s mucin core antigen. In turn, pre-blocking of C595 with a 20 amino-ac
id mucin core peptide specifically inhibited binding of 91 1 antibody
to C595. Cross-reactivity of antibody 91 1 was only observed against t
he IgM MAb, 789/9 1, which has the same minimum antibody-binding epito
pe as C595, namely, R P A P. Syngeneic and xenogeneic anti-sera agains
t 91 1 antibody displayed increased binding to heptameric peptide sequ
ences containing the motif, R P A(P). The anti-idiotypic antibody 911
therefore appears to recognize a site within or close to the binding s
ite of the C595 antibody and thus carries an internal image of the par
ental mucin epitope. Consequently, the 91 1 idiotypic network offers a
promising model system to investigate the mechanism of anti-idiotype-
induced tumour immunity. (C) 1993 Wiley-Liss, Inc.